Aesthetic Medicine Market Size To Rake USD 191.70 Bn By 2032

The global aesthetic medicine market size was valued at USD 83.27 billion in 2023 and it is projected to reach around USD 191.70 billion by 2032 with a CAGR of 9.71% from 2023 to 2032.

Approximately 36% of the Global Aesthetic Medicine Market Captured by North America

The rapidly shifting consumers’ attitude towards beauty, wellness, and aging has surged the awareness and acceptance of aesthetic medicines and procedures, which has resulted in an increasing demand for the aesthetic medicines among the men. US is the largest market in North America. The presence of aesthetic treatment services via beauty bars, med spas, and aesthetic clinics in the region has significantly fostered the growth of the aesthetic medicine market. The rapidly aging population in US is expected to be a prominent growth driver of the market in the upcoming future. It is estimated that around 24% of the total population in US will constitute the elderly population by 2060. The rising concerns among the middle and high income groups regarding their physical appearance are expected to boost the demand for the aesthetic medicine in US. Botox injection is the leading procedure and the most demanded procedure in North America. According to the American Society of Plastic Surgeons Botox injections procedures has increased by around 845% between 2000 and 2018.

Get a Sample:https://www.precedenceresearch.com/sample/1667

What are the key trends in the Global Aesthetic Medicine Market?

The growing urge among the people to look young and fit is fueling the demand for the aesthetic medicine in the developed and developing economies. The rapidly surging popularity of the non-invasive and minimally invasive surgical procedures is driving the growth of the aesthetic medicine market across the globe. The demand for the cosmetics surgery is boosting the growth of the aesthetic medicine market. The rising adoption of advanced laser resurfacing technology and aesthetic injectable is propelling the growth of the aesthetic medicines globally. Furthermore, the economic benefits and conveniences associated with the minimally invasive procedures like less pain and quick recovery is fostering its demand among the consumers.

What are the key challenges in the Global Aesthetic Medicine Market?

There is a risk of potential side effects associated with the aesthetic procedures. There are certain complications and risks that the consumers may face during or after the procedure. The associated risks are the major factor that may restrict the consumers to adopt the aesthetic treatments. Furthermore, the high costs involved with the treatment and the low awareness in the developing and underdeveloped economies may hamper the market growth during the forecast period. Furthermore, the manufacturers faces a complicated regulations pertaining to the commercialization of various aesthetic medicines.

Table of Contents

Aesthetic Medicine Market Scope

Report Coverage	Details
Market Size by 2032	USD 191.70 Billion
Growth Rate from 2023 to 2032	CAGR of 9.71%
North America Market Share in 2022	36.1%
Non-invasive Procedures Segment Market Share in 2022	51%
Base Year	2022
Forecast Period	2023 to 2032
Segments Covered	Procedure, Product, Application, End-User, Gender, Route of Administration, Geography

Asia Pacific is expected to grow at the highest CAGR of 10.7% during the forecast period

The emerging economies like China, India, and South Korea are the growth drivers of the Asia Pacific aesthetic medicine market. South Korea has become a hub for aesthetic treatments owing to the presence of advanced treatment facilities and skilled cosmetics surgeons. The rising awareness among the population regarding the availability of various invasive and non-invasive procedures to improve the aesthetic appearances and anti-aging injectable is boosting the growth of the market. The rapidly growing geriatric population in the region is projected to increase the demand for the aesthetic medicines in the forthcoming years. According to the United Nations, the low and middle income countries are expected to be the home of around 80% of the global geriatric population by 2050. Furthermore, around 93% of the road traffic accidents occur in low and middle income nations, which also contribute towards the increasing demand for the aesthetic medicine market in Asia Pacific. The rising technological advancements and rising penetration of the aesthetic treatment products in the region coupled with rising personal disposable income is augmenting the growth of the aesthetic medicine market in Asia Pacific.

Cosmetic Implants Market Companies

AbbVie Inc.
Galderma
Alma Lasers
Cynosure
Johnson & Johnson Private Limited
Lumenis Be Ltd.
Solta Medical
Candela Medical
Hologic, Inc.
Dentsply Sirona

Segments Covered in the Report

By Procedure Type

Non-Invasive Procedure
- Botox Injections
- Microdermabrasion
- Soft Tissue Fillers
- Laser Hair Removal
- Chemical Peel
- Others
Invasive Procedure
- Liposuction
- Nose Reshaping
- Breast Augmentation
- Tummy Tuck
- Eyelid Surgery
- Others

By Product Type

Energy-Based Devices
- Laser-based Aesthetic Device
- Radiofrequency (RF)-based Aesthetic Device
- Light-based Aesthetic Device
- Ultrasound Aesthetic Device
- Others
Implants
- Facial Implants
- Breast Implants
- Others
Anti-Wrinkle Products
Botulinum Toxin
Dermal Fillers
Others

By Application

Surgical
Non-Surgical

By End-User

Medical Spas and Beauty Centres
Hospitals and Clinics
Ambulatory Surgical Centers
Home Use

By Gender

Males
- 18 years and below
- 19-34 years
- 35-50 years
- 51-64 years
- 65 years and above
Females
- 18 years and below
- 19-34 years
- 35-50 years
- 51-64 years
- 65 years and above

By Route of Administration

Oral
Topical

By Geography

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa